175 related articles for article (PubMed ID: 19863207)
1. Case Study: using a continuous glucose monitoring system in a patient with diabetes and beta-thalassemia hemoglobinopathy.
Al-Futaisi A; Wali Y; El-Beshlawi I; Al-Riyami S; Almahrezi A
Pediatr Hematol Oncol; 2009; 26(7):515-9. PubMed ID: 19863207
[TBL] [Abstract][Full Text] [Related]
2. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of continuous glucose monitoring system for detection of alterations in glucose homeostasis in pediatric patients with β-thalassemia major.
El-Samahy MH; Tantawy AA; Adly AA; Abdelmaksoud AA; Ismail EA; Salah NY
Pediatr Diabetes; 2019 Feb; 20(1):65-72. PubMed ID: 30378745
[TBL] [Abstract][Full Text] [Related]
4. Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practice.
Anderson J; Attvall S; Sternemalm L; Pivodic A; Fahlén M; Hanås R; Ekeroth G; Lind M
J Diabetes Sci Technol; 2011 Nov; 5(6):1472-9. PubMed ID: 22226268
[TBL] [Abstract][Full Text] [Related]
5. Benefits of short-term professional continuous glucose monitoring in clinical practice.
Leinung M; Nardacci E; Patel N; Bettadahalli S; Paika K; Thompson S
Diabetes Technol Ther; 2013 Sep; 15(9):744-7. PubMed ID: 23786229
[TBL] [Abstract][Full Text] [Related]
6. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
[TBL] [Abstract][Full Text] [Related]
7. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
8. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
9. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy.
Kosecki SM; Rodgers PT; Adams MB
Ann Pharmacother; 2005 Sep; 39(9):1557-60. PubMed ID: 16076916
[TBL] [Abstract][Full Text] [Related]
10. Managing diabetes in hospitalized patients with chronic kidney disease.
Iyer SN; Tanenberg RJ
Cleve Clin J Med; 2016 Apr; 83(4):301-10. PubMed ID: 27055204
[TBL] [Abstract][Full Text] [Related]
11. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
Divani M; Georgianos PI; Didangelos T; Iliadis F; Makedou A; Hatzitolios A; Liakopoulos V; Grekas DM
Am J Nephrol; 2018; 47(1):21-29. PubMed ID: 29275415
[TBL] [Abstract][Full Text] [Related]
13. Assessment of quality of glycemic control in intensive care patients treated with an insulin infusion at a teaching hospital.
Gauthier L; Ferguson J; Dubé AI; Nguyen PV; Beauchesne MF; Boutin JM
Can J Diabetes; 2014 Apr; 38(2):139-43. PubMed ID: 24690509
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.
Conget I; Castaneda J; Petrovski G; Guerci B; Racault AS; Reznik Y; Cohen O; Runzis S; de Portu S; Aronson R;
Diabetes Technol Ther; 2016 Jan; 18(1):22-8. PubMed ID: 26241790
[TBL] [Abstract][Full Text] [Related]
15. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
[TBL] [Abstract][Full Text] [Related]
16. [Implantable artificial endocrine pancreas].
Shichiri M; Nishida K; Sakakida M; Araki E
Nihon Rinsho; 2002 Sep; 60 Suppl 9():620-4. PubMed ID: 12387060
[No Abstract] [Full Text] [Related]
17. Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide.
Roach ; Koledova E; Metcalfe S; Hultman C; Milicevic Z;
Clin Ther; 2001 Oct; 23(10):1732-44. PubMed ID: 11726007
[TBL] [Abstract][Full Text] [Related]
18. The Comprehensive Glucose Pentagon: A Glucose-Centric Composite Metric for Assessing Glycemic Control in Persons With Diabetes.
Vigersky RA; Shin J; Jiang B; Siegmund T; McMahon C; Thomas A
J Diabetes Sci Technol; 2018 Jan; 12(1):114-123. PubMed ID: 28748705
[TBL] [Abstract][Full Text] [Related]
19. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
20. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study.
Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B
Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
